(Q47567258)

4 February 2018

title

Resurrecting DNAzymes as sequence-specific therapeutics (English)

1 reference

4 February 2018

author name string

John J Rossi

series ordinal

1

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 June 2012

1 reference

4 February 2018

Science Translational Medicine

published in

1 reference

4 February 2018

volume

4

1 reference

4 February 2018

issue

139

1 reference

4 February 2018

page(s)

139fs20

1 reference

4 February 2018

The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004080

The intervening sequence RNA of Tetrahymena is an enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004080

Simple RNA enzymes with new and highly specific endoribonuclease activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004080

A general purpose RNA-cleaving DNA enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004080

DNAzyme technology and cancer therapy: cleave and let die.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004080

Toxicology of antisense therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004080

Overcoming the innate immune response to small interfering RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004080

Sequence- and target-independent angiogenesis suppression by siRNA via TLR3

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3004080

10.1126/SCITRANSLMED.3004080

21 January 2018

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

22723461

1 reference

4 February 2018